Herpes simplex virus recurrences are common, but cell-mediated immunity, not antibodies, influences relapses. New diagnostic tools and systemic treatments, like thymopentin, show promise for managing herpes simplex virus (HSV) infections.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: